• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Repligen Corp

+ Add to Watchlist

RGEN:US

20.2799 USD 0.0901 0.44%

As of 15:20:18 ET on 08/22/2014.

Company Profile for Repligen Corp (RGEN)

Repligen Corporation is a biotechnology company. The Company develops therapeutics for the treatment of diseases of the central nervous system. Repligen owns owns intellectual property on monoclonal antibody and antibody fusion products.

Contact Information

Repligen Corp

41 Seyon Street
Building 1 Suite 100
Waltham, MA 02453
United States
Phone: 1-781-250-0111
Fax: 1-781-250-0115

Key Executives for Repligen Corp (RGEN)

Walter C HerlihyPresident/CEO/TreasurerJon K SnodgresChief Financial Officer
Tony J HuntChief Operating OfficerJames R RuscheSenior VP:Research & Dev
Howard BenjaminVP:Business DevelopmentSondra S NewmanDirector:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil